DYN
NASDAQ
$23.83
Dyne Therapeutics Inc (DYN)
Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $39.20 (+64.50%)
Market Cap
$3.96B
PEG Ratio
0.19
Free Cash Flow Yield
-11.19%
Beta (5Y)
1.77
Price Chart
Valuation
Market Cap$3.96B
PEG0.19
P/B4.52
Profitability
EBITDA-$469M
EPS-$3.14
Financial Health
Debt-to-Equity17.3%
Free Cash Flow Yield-11.19%
Growth & Risk
Beta (5Y)1.77
Sharpe Ratio1.49